Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eucerin Dry Skin Relief 3% lotion with urea
1302010U0BGABAL
|
Eucerin | Urea | Skin | 1 |
|
Finasteride 1mg tablets
1309000W0AAAAAA
|
Finasteride (Scalp) | Finasteride | Skin | 1 |
|
Gam-O 40mg capsules
1305010I0BUAAAA
|
Gam-O | Gamolenic acid | Skin | 1 |
|
Generic Aveeno cream
130201000AAA8A8
|
Generic compound emollients | Other emollient preparations | Skin | 1 |
|
Generic Dermol 200 shower emollient
130201100AAANAN
|
Generic compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 1 |
|
Generic Dermol 500 lotion
130201000AABWBW
|
Generic compound emollients | Other emollient preparations | Skin | 1 |
|
Generic Oilatum Plus bath additive
1302011L0AAADAD
|
Light liquid paraffin | Light liquid paraffin | Skin | 1 |
|
Glycopyrronium bromide 0.5% in Generic Unguentum M cream
1312000G0AABIBI
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 1 |
|
Glycopyrronium bromide 2% cream
1312000G0AAANAN
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 1 |
|
Glycopyrronium bromide 4% cream
1312000G0AAATAT
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 1 |
|
Glycopyrronium bromide powder for solution for iontophoresis
1312000G0AAAAAA
|
Glycopyrronium (Topical) | Glycopyrronium bromide | Skin | 1 |
|
Hamamelis water
1311060H0AAAAAA
|
Hamamelis (Topical Cleanser) | Hamamelis | Skin | 1 |
|
Hydrocortisone acetate 1% / Sodium fusidate 2% ointment
1304000X0AACGCG
|
Hydrocortisone acetate (Topical) | Hydrocortisone acetate | Skin | 1 |
|
Icthaband bandage 7.5cm x 6m
1305010AEBBAAAA
|
Icthaband | Zinc paste and ichthammol | Skin | 1 |
|
Industrial methylated spirit 70% / Glycerol 1% gel
1311010A0AAAKAK
|
Industrial methylated spirit | Alcohol | Skin | 1 |
|
Lactic acid 10% in Aqueous cream
1302010K0AAAFAF
|
Lactic acid (Topical) | Lactic acid | Skin | 1 |
|
Lansinoh HPA Lanolin cream
1301010W0BBABAC
|
Lansinoh | Wool fat | Skin | 1 |
|
Larvae 100 Boot pack
1311070S0BBAYAA
|
LarvE | Ster larvae | Skin | 1 |
|
LarvE BioFOAM 2.5cm x 4cm maintenance dressing
1311070S0BBALAA
|
LarvE | Ster larvae | Skin | 1 |
|
Medicated Talc 0.5% powder
130203000BRAIA0
|
Proprietary compound preparation BNF 1302030 | Other dusting powder preparations | Skin | 1 |
|
Metronidazole 1% cream
1310012K0AABJBJ
|
Metronidazole (Topical) | Metronidazole | Skin | 1 |
|
Metrotop 0.8% gel
1310012K0BBAAAQ
|
Metrotop | Metronidazole | Skin | 1 |
|
Mineralised methylated spirit
1311010A0AAAFAF
|
Industrial methylated spirit | Alcohol | Skin | 1 |
|
Minoxidil 2% gel
1309000H0AAAKAK
|
Minoxidil (Scalp) | Minoxidil | Skin | 1 |
|
Modrasone 0.05% cream
1304000B0BBAAAA
|
Modrasone | Alclometasone dipropionate | Skin | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.